• Effectiveness of Primary Treatment for Elderly than 75 Years with Prostate Cancer- Korean National Health Insurance Database

    May 1, 2018, 00:00

  • Body Mass Index and Obesity-Related Comorbidities Among Patients Aged65 Years Undergoing Bariatric Surgery- Comparison Between Medicare and Commercially-Insured

    May 1, 2018, 00:00

  • Delphi Method- A Qualitative Approach For Quantitative Results

    May 1, 2018, 00:00

  • Prescription Opioid Use Among Children and Adolescents with Asthma in the United States- National Estimates from 2011 to 2015

    May 1, 2018, 00:00

  • Modified Drug Adherence Work-Up (M-DRAW) Tool in Patients With Diabetes at Veterans Affairs Health System- Tool Validation And Preliminary Result

    May 1, 2018, 00:00

  • Degree of Agreement Between Randomized Controlled Trials and Observational Studies on Drug Effects- A Systematic Review

    May 1, 2018, 00:00

  • National Trends in Utilization of Bariatric Surgery

    May 1, 2018, 00:00

  • Clopidogrel Versus Aspirin For The Treatment Of Acute Coronary Syndrome After A 12-Month Dual Antiplatelet Therapy- A Cost-Effectiveness Analysis From China Payer’s Perspective

    May 1, 2018, 00:00

  • Using Electronic Health Records to Examine HPV Vaccine Initiation and Completion Rates

    May 1, 2018, 00:00

  • The Elephant(S) in the Room – Aggrandizement of STA Guidance Workload for Nice

    May 1, 2018, 00:00

  • Quality of Life and Functional Impairment Results- A Prospective Real-World Dyskinesia Screening Study and Registry in Patients Taking Antipsychotic Agents

    May 1, 2018, 00:00

  • Comparative Analysis Investigating the Impact of Implant Design on Hospital Length of Stay and Discharge Destination in a Dutch Hospital with an Established Enhanced Recovery Program

    May 1, 2018, 00:00

  • History of Lipid Lowering Therapy and Cardiovascular Medication Use Among Patients Initiating PCSK9 Inhibitors in the United States

    May 1, 2018, 00:00

  • Evolution of Regulatory Requirements for Retrospective Observational Studies Using Medical Records in Austria, Belgium, Italy, Netherlands and Switzerland

    May 1, 2018, 00:00

  • Economic Burden Of Locally Advanced Or Metastatic Merkel Cell Carcinoma In The United States- An Analysis Of Electronic Health Records

    May 1, 2018, 00:00

  • US Lupus Trends 2009-2017- Results from the National Health and Wellness Survey

    May 1, 2018, 00:00

  • Estimating the Current Cost of Endoscopic Sinus Surgery in the US – A Claims-Based Approach

    May 1, 2018, 00:00

  • Results of a Targeted Literature Review on the Cost-Effectiveness Models Developed for Retinopathy of Prematurity

    May 1, 2018, 00:00

  • An Analytical Framework for Economic Evaluation of Interventions with Effects on Multiple Outcomes, Costs Falling on Different Budgets, and Involving More than One Decision Maker

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of High-Sensitivity Troponin T Versus Conventional Troponin I Testing for Acute Myocardial Infarction

    May 1, 2018, 00:00

  • Budget Impact Analysis of a Novel Alternating Pressure Support Surface in the Acute Care Setting

    May 1, 2018, 00:00

  • Medium Term Effect on Direct Medical Costs of Pediatric Pulmonary Hypertension Health Care with Specific Treatment in in Centro Medico Nacional 20 De Noviembre (Nmcissste, Mexico)

    May 1, 2018, 00:00

  • Perceived Value of Health Insurance and Enrollment Decision Among Low-Income Population

    May 1, 2018, 00:00

  • Assessing Readiness of US Community Rheumatologists for Implementation of Medicare Access and Chip Reauthorization act (MACRA), Merit-Based Incentive Payment System (MIPS) and Alternative Payment Models (APMS)

    May 1, 2018, 00:00

  • Impact of 2017 Policy Changes on China's Pharmaceutical Market

    May 1, 2018, 00:00

  • Prescription Pattern Of Opioids Among Prostate Cancer Patients Of Various Racial Groups

    May 1, 2018, 00:00

  • The Economic Burden of Overactive Bladder (OAB) in Brazil- A Retrospective Observational Study Using Data from the Sistema Unico De Saude (SUS)

    May 1, 2018, 00:00

  • Cost-Effectiveness of Tofacitinib in Patients with Rheumatoid Arthritis in China

    May 1, 2018, 00:00

  • Changes in Fda Post-Marketing Commitments to Support The Pregnancy and Lactation Labeling Rule

    May 1, 2018, 00:00

  • Budget Impact Analysis with Simultaneous Multiple Market Entrants- Static Versus Dynamic Baseline Market Shares

    May 1, 2018, 00:00

  • Economic Outcomes of Medicare Reimbursement Policy Change on Erythropoiesis-Stimulating Agents in Cancer Patients

    May 1, 2018, 00:00

  • Payer Coverage and Evidence Requirements for Oncology Liquid Biopsy Testing in the United States- Current State and Filling The Gaps

    May 1, 2018, 00:00

  • Patella Fracture- Cost, Complications and Treatments in the Commercially-Insured Population

    May 1, 2018, 00:00

  • Association Between Inhaled Corticosteroids and Pneumonia in Asthma Patients

    May 1, 2018, 00:00

  • Adopting a Pragmatic Methodology to Evaluate Cost-Effectiveness of a Simple Insulin Infusion Device Compared with Multiple Daily Injections in Patients with Type 2 Diabetes on Insulin

    May 1, 2018, 00:00

  • Valuation of Preference-Based Measures- Can Existing Preference Data be Used to Select a Smaller Sample of Health States?

    May 1, 2018, 00:00

  • Budget Impact Analysis of Cladribine Tablets for Treatment Of Patients with Relapsing-Remitting Multiple Sclerosis In Bulgaria

    May 1, 2018, 00:00

  • Burden of Illness of Chronic Hepatitis C in Medicaid

    May 1, 2018, 00:00

  • Comparing Clotting Factors Benefit-Risk Attributes Across Different Methods of Preference Elicitation In Hemophilia Patients

    May 1, 2018, 00:00

  • Budget Impact Analysis of Tafluprost/Timolol Maleate for Lowering Intraocular Pressure (IOP) in Adult Patients with Open-Angle Glaucoma or Ocular Hypertension in Bulgaria

    May 1, 2018, 00:00

  • Healthcare Resource Utilization of Conjunctivitis in the General Population and in Patients with Prior Antibiotic-Resistant Infection- A Retrospective US Claims-Based Analysis

    May 1, 2018, 00:00

  • Association Between Recombinant Tissue Plasminogen Activator and In-Hospital Mortality/30-Day Readmission Among Mechanical Thrombectomy Patients- A Retrospective Cohort Study

    May 1, 2018, 00:00

  • Using Time Trade-Off (TTO) Surveys To Measure Health Utilities Associated with Different Urinary Catheter Innovations

    May 1, 2018, 00:00

  • Screening for and Addressing Social Determinants of Health in Managed Care

    May 1, 2018, 00:00

  • What Factors May Impact the Likelihood of First Abbreviated New Drug Application (ANDA) Submission for a Reference Product?

    May 1, 2018, 00:00

  • Long-Term Health Benefit of Ibalizumab In The Treatment of Adults with Multidrug-Resistant HIV-1 Infection

    May 1, 2018, 00:00

  • Racial/Ethnic Differences in the Treatment of Adolescent Major Depressive Disorders (MDD) Across Healthcare Providers Participating in the Medicaid Program

    May 1, 2018, 00:00

  • Programmed Cell Death Ligand-1 Testing Among Patients With Metastatic Non-Small Cell Lung Cancer- A Multinational Medical Record Review Study

    May 1, 2018, 00:00

  • Comparison of Costs Associated with Turp and Prostatic Urethral Lift for Benign Prostatic Hyperplasia

    May 1, 2018, 00:00

  • Perception of Students in Health Professions Towards Influenza Vaccination- A Web-Survey at a Private Midwestern University

    May 1, 2018, 00:00

  • Self-Reported Pain Outcomes of Pharmacists with Chronic Pain

    May 1, 2018, 00:00

  • Use of Vascular Closure Devices in the Hospital Setting for Percutanous Coronary Procedures and Gender Differences of the Mynx® Vascular Closure Devi Results from a Hospital Claims Analysis

    May 1, 2018, 00:00

  • Adaptive Licensing and Real World Evidence (RWE)

    May 1, 2018, 00:00

  • Real-World Analysis of Treatment Patterns and Long-Term Effectiveness Among Patients with Advanced Neuroendocrine Tumors of Lung Origin (Lung Net)- A Multicenter Study

    May 1, 2018, 00:00

  • Giapreza For The Treatment Of Severe Distributive Shock In The Intensive Care Unit- A US Cost-Effectiveness Analysis

    May 1, 2018, 00:00

  • The Horse(SAS) Now has a Cart – Comparing Sas to Salford System’s Categorization and Regression Tree Procedures

    May 1, 2018, 00:00

  • Cost-Effectiveness of Ibrutinib and Rituximab for the Relapsed or Refractory Chronic Lymphocytic Leukemia in China

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Biologic Therapies for Treatment of Psoriatic Arthritis

    May 1, 2018, 00:00

  • The Prevalence of Comorbidities and Its Association with Poor Glycemic Control in Malaysian Patients with Type 2 Diabetes Mellitus

    May 1, 2018, 00:00

  • Sociodemographic Disparities in Health-Related Quality of Life Within a Safety Net Primary Care Setting and the Clinical Implications of Symptom Management

    May 1, 2018, 00:00

  • Hospitalization Costs for Treatment of Periprosthetic Fractures of the Knee Using Medicare Claims and A Hospital Billing Data in the United States

    May 1, 2018, 00:00

  • Merging of the Pediatric Interagency Registry for Mechanically Assisted Circulatory Support (PediMACS) with an Exyernal Administrative Database Using Indirect Patient Identifiers to Develop a More Comprehensive Platform for Health Economics ...

    May 1, 2018, 00:00

  • Healthcare Resources Patterns and Cost Analysis of Pulmonary Arterial Hypertension in a Tertiary Care Setting In Mexico City

    May 1, 2018, 00:00

  • Real-World Data Analysis Of Metastatic Castration-Resistant Prostate Cancer (MCRPC) Treatment Decisions With The Introduction Of Newer Treatment Options

    May 1, 2018, 00:00

  • Assessment-Time Bias- Statistical Approaches to Adjusting for Between-Trial Differences in the Schedule of Assessment for Disease Progression In Immuno-Oncology Trials

    May 1, 2018, 00:00

  • Cost-Utility Analysis of two Ultrasound-Guided Breast Biopsies- Vacuum-Assisted Biopsy Versus Conventional Core Needle Biopsy

    May 1, 2018, 00:00

  • Effectiveness of Korean Medicine Therapy for Parkinson’s Disease Management- National Health Insurance Service-National Sample Cohort (NHIS-NSC)

    May 1, 2018, 00:00

  • Review of Frequently Implemented Patient Reported Outcomes in Current Prostate Cancer Clinical Trials

    May 1, 2018, 00:00

  • Impact of Chlorhexidine Bathing on Antimicrobial Utilization in Surgical Intensive Care Unit Patients- A Secondary Analysis of a Single-Center Randomized Controlled Trial

    May 1, 2018, 00:00

  • A Naturalistic Observation Study of Current Medication Counseling Practices at Retail Chain Pharmacies in the Houston Area

    May 1, 2018, 00:00

  • Assessment of Work Loss and Costs Associated with Opioid Abuse- A Retrospective Claims Analysis

    May 1, 2018, 00:00

  • Treatment Patterns PSO

    May 1, 2018, 00:00

  • Cost-Effectiveness of Regular Utilization of Zoledronic Acid for Developed Bone Metastases from Advanced Breast Cancer in Chinese Patients

    May 1, 2018, 00:00

  • Improved Outcomes and Neutral Hospital Budget Impact Associated with Flowable Gelatin for Lumbar Surgery in a Chinese Tertiary Care Hospital- A Retrospective Case-Series Study

    May 1, 2018, 00:00

  • Hospital Lenght of Stay and Costs in Patients with Post Operative Wound Infection- Analysis of US National In-Patient Data for 2015 Using ICD-9 and ICD-10 Diagnoses

    May 1, 2018, 00:00

  • A Qualitative Physician Focus Group Study to Determine How Physicians Decide What Second-Line Therapy to Prescribe for Patients with Type 2 Diabetes (T2DM)

    May 1, 2018, 00:00

  • Economic Impact of Absenteeism and Deaths Due to Pneumonia in Brazilian Economy

    May 1, 2018, 00:00

  • Psychometric Analyses of Pros in Bronchiectasis

    May 1, 2018, 00:00

  • Financial Benefit of a New Ultrasonic Energy Device in Open and Laparoscopic Procedures

    May 1, 2018, 00:00

  • Off-Label Chemotherapy In Cancer- A Review Of Current Coverage Landscape And Reimbursement Considerations

    May 1, 2018, 00:00

  • How Will Payers Manage The High Cost Of Combinations Of New Oncology Agents, As Many Of These Therapies Become The Preferred Treatment Options To Optimize Patient Outcomes?

    May 1, 2018, 00:00

  • Medium Term Tendency of Annual Direct Medical Cost of Pediatric Pulmonary Hypertension Health Care in Centro Medico Nacional 20 De Noviembre (Nmcissste, Mexico)

    May 1, 2018, 00:00

  • Male Osteoporosis Highly Underdiagnozed in Bulgaria – A Retrospective Analysis

    May 1, 2018, 00:00

  • Are all Endoscopic Surgical Staplers the Same? Findings From a Real-World Assessment in Bariatric Procedures

    May 1, 2018, 00:00

  • Assessing Hospital Utilization of Patients Diagnosed with Marfan Syndrome

    May 1, 2018, 00:00

  • Prospective Evaluation of Anterior Cruciate Ligament Reconstruction Outcomes with the Knee Injury and Osteoarthritis Score (Koos)

    May 1, 2018, 00:00

  • Hepatitis C Patient Characteristics and Overall Charges from an Integrated Health Care Delivery System

    May 1, 2018, 00:00

  • Comorbidities, Complications, and Surgical Procedures in Type 2 Diabetes Patients- Retrospective Analysis of Electronic Health Record Data

    May 1, 2018, 00:00

  • Survey Results of Contemporary Us Health Plan Policies – Affordable Care Act (ACA), Digital Technologies, Value Based Contracting (VBC) And Comparative Effectiveness Research (CER)

    May 1, 2018, 00:00

  • Long-Term Epidemiological Impact of Pertuzumab+Trastuzmab on Metastatic Breast Cancer Incidence in Canada

    May 1, 2018, 00:00

  • HIV Treatment Guidelines and Medication Initiation Patterns in Treatment Naïve Adults, 2008-2016

    May 1, 2018, 00:00

  • The Impact Of Medicare Part D Drug Coverage On Total Prescription Drug Expenditures Among Cancer Patients In 2014

    May 1, 2018, 00:00

  • Cost-Effectiveness of Mepolizumab Versus Omalizumab as an Adjunct Therapy in Patients with Uncontrolled Allergic Asthma

    May 1, 2018, 00:00

  • Systematic Literature Review of Real-World Evidence on Adherence with Biologics in Inflammatory Bowel Disease in the United States

    May 1, 2018, 00:00

  • Mission Possible? Demonstrating Robust Cost-Effectiveness without Any Comparative Phase 3 Data

    May 1, 2018, 00:00

  • Treatment Patterns and Medicaid Spending in Comorbid Schizophrenia Populations- Once-Monthly Paliperidone Palmitate Vs Oral Atypical Antipsychotics

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Myostrain in Suspected Coronary Artery Disease Patients

    May 1, 2018, 00:00

  • Comparison of Structured Versus Abstracted Comorbidities Using Oncology EHR Data from Cancer Patients in the Flatiron Health Network

    May 1, 2018, 00:00

  • Burden of Chronic Hepatitis C (CHC) from the Patient Perspective- A Literature Review and Conceptual Map

    May 1, 2018, 00:00

  • Comparative Efficacy of Consolidation Therapy After Chemoradiation Therapy (CRT) in Patients with Unresectable, Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)- A Network Meta-Analysis

    May 1, 2018, 00:00

  • A Time-Motion Observational Study of Clinic Staff- Administration of Pegfilgrastim Primary Prophylaxis Via Next-Day Manual Injection and On-Body Injector (OBI)

    May 1, 2018, 00:00

  • Polypharmacy Use Among Patients with Diabetes- A Cross-Sectional Retrospective Study

    May 1, 2018, 00:00

  • Veno-Occlusive Disease (VOD) Associated with Gemtuzumab Ozogamicin (GO) and Inotuzumab Ozogamicin- Analysis of the FDA Adverse Event Reporting System

    May 1, 2018, 00:00

  • Prescription Drug Coverage for Treatment of Low Back Pain Among U.S. Medicaid, Medicare Advantage and Commercial Insurers

    May 1, 2018, 00:00

  • Multi-Level Predictors of Discharges Against Medical Advi Decomposing Variation Using an All-Payer Database

    May 1, 2018, 00:00

  • Disposable vs. Fiber Optic Reusable Bronchoscopes for High-Risk Procedures- Cost-Effectiveness Analysis (CEA)

    May 1, 2018, 00:00

  • The Association Between Preoperative Hemoglobin Values and Hospitalization Outcomes Following Elective Primary Total Joint Replacement

    May 1, 2018, 00:00

  • Challenges in Translating the Sheehan Suicidality Tracking Scale (Updated Adult Version)

    May 1, 2018, 00:00

  • Cancer-Associated Venous Thromboembolism (VTE) Prophylaxis- A Comparative Effectiveness Research

    May 1, 2018, 00:00

  • Population Models Suppporting Decision Making on a Policy Level – A Systematic Review

    May 1, 2018, 00:00

  • Cancer Drug Reimbursement Decision-Making in the Republic of Ireland- Can the Process Be Made More Transparent and Systematic?

    May 1, 2018, 00:00

  • Correlates of Oncology Drug Prices in the U.S

    May 1, 2018, 00:00

  • The Relationship Between Compliance and Blindness Prevention in Economic Models for Diabetic Retinopathy Screening

    May 1, 2018, 00:00

  • Alzheimer’s Attributable Costs in the United States- A Secondary Analysis of Medical Expenditure Panel Survey 2011-2015

    May 1, 2018, 00:00

  • Geographic Variation in Opioid Related Inpatient Healthcare Utilization in the United States- A Retrospective Study of a Large Health System’s Claims Data

    May 1, 2018, 00:00

  • Poor Medication Adherence and High Rates of Treatment Discontinuation Among SCD Patients Treated with Hydroxyurea

    May 1, 2018, 00:00

  • Prior Perceptions and Subsequent Decisional Conflict Regarding HIV Cure Trial Participation in Bangkok, Thailand

    May 1, 2018, 00:00

  • Progressive Primary Multiple Sclerosis (PPMS)- Where Disability is Growing and Treatment is Absent

    May 1, 2018, 00:00

  • Examining Epidemiological Burden of Sepsis in the Chinese Population Using a Focused Literature Review

    May 1, 2018, 00:00

  • Estimating the Global Diagnosed Prevalence of Crohn's Disease 2017-2027

    May 1, 2018, 00:00

  • Projected Savings in Direct and Indirect Costs Due to Reduced Diabetes Prevalence with Vegetarian Diets

    May 1, 2018, 00:00

  • The Cost Of Integrating Whole Genome Sequencing Into The Care Of Cardiomyopathy Patients- Sensitivity And Scenario Analyses

    May 1, 2018, 00:00

  • Comparing the EQ-5D-3L and EQ-5D-5L in a Cohort of Cancer Patients

    May 1, 2018, 00:00

  • Model-Based Evaluation of the Efficacy and Safety of Burosumab, A Fully Human Anti-FGF23 Monoclonal Antibody, In Adolescent X-Linked Hypophosphatemia (XLH)

    May 1, 2018, 00:00

  • Are mother’s Behavior, Health Status, and Birth Experience Associated with Low Birth Weight in South Carolina? Evidence from Prams, 2004-2013

    May 1, 2018, 00:00

  • Real-World Treatment Patterns And Care Pathways In Metastatic Castration Resistant Prostate Cancer

    May 1, 2018, 00:00

  • Real-World EQ-5D-5L Utility Values In Patients With Melanoma Derived Using A Digital ‘Bring Your Own Device’ Platform

    May 1, 2018, 00:00

  • Do Fathers of a Newborn get Depressed? Paternal Postnatal Depression in Riyadh, Saudi Arabia

    May 1, 2018, 00:00

  • Concepts and Instruments for Patient-Reported (PRO) Assessment in Celiac Disease- Literature Review and Stakeholder Perspectives

    May 1, 2018, 00:00

  • Cost Analysis Model for the Treatment of Acute Agitation Among Patients with Schizophrenia in China

    May 1, 2018, 00:00

  • Measuring Treatment Satisfaction with Medication from Patients’ Perspective- Conceptual Models and a Review of Measures

    May 1, 2018, 00:00

  • Cost Per Response of Certolizumab Pegol Versus Adalimumab Among Biologic-Naïve Patients With Moderate or Severe Rheumatoid Arthritis from the US Payer Perspective

    May 1, 2018, 00:00

  • Clinical Utility of Promis Domain Scales- Thresholds for Determining Responsiveness Following Stroke

    May 1, 2018, 00:00

  • Acute Healthcare Utilization Patterns Among People with Type 2 Diabetes Using Professional CGM in the United States

    May 1, 2018, 00:00

  • Healthcare Costs Associated with Hyperprolactinemia in the United States

    May 1, 2018, 00:00

  • Predictors of Laparoscopic Hysterectomy for Leiomyoma Surgical Removal in the United States

    May 1, 2018, 00:00

  • Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach

    May 1, 2018, 00:00

  • Rifaximin and Eluxadoline Utilization for Irritable Bowel Syndrome with Diarrhea (IBS-D) in the United States and Budget Impact Analysis of Switching from Eluxadoline to Rifaximin

    May 1, 2018, 00:00

  • Coverage and Reviews of Medical Devices, Genomic and Diagnostic Testing by US Health Plans

    May 1, 2018, 00:00

  • Quality Assurance Metrics for Prostate Cancer Treatment Plans in the Private Healthcare Environment

    May 1, 2018, 00:00

  • Real-World, Non-Interventional, Observational, Patient Reported Outcome Study for Evaluating Effectiveness of Intensive Moisturizing Cream with Plant Based Butters (Venusia Max) in Management of Indian Patients with Psoriasis

    May 1, 2018, 00:00

  • Evaluating the Effect of The Change in ACC/AHA Blood Pressure Guidelines on The Prevalence of Diagnosed Hypertension

    May 1, 2018, 00:00

  • Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults

    May 1, 2018, 00:00

  • Cost-Effective Study of Alectinib in Treating Crizotinib-Failed Anaplastic Lymphoma Kinase Positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Patients in Taiwan

    May 1, 2018, 00:00

  • Hepatitis B Virus (HBV) Vaccine in Pregnancy and Impact on Pregnancy Outcome

    May 1, 2018, 00:00

  • Applying Population Health Management Techniques to Lower Healthcare Utilization in Patients with Non-Chronic Complex Diseases

    May 1, 2018, 00:00

  • Assessment of Commercial and Market Access Potential and Considerations for an Ultra-Orphan Drug for Renal Disease in EU5

    May 1, 2018, 00:00

  • Comparative Effectiveness Of Edoxaban And Warfarin In Prevention Of Stroke And Systemic Embolism In Non-Valvular Atrial Fibrillation Using Observational Healthcare Data

    May 1, 2018, 00:00

  • Outpatient Antibiotic Use and Revisits for Children with Acute Respiratory Tract Infections

    May 1, 2018, 00:00

  • Medication Synchronization Improves Medication Adherence

    May 1, 2018, 00:00

  • Comparison of Buprenorphine and Methadone Based Medication Assisted Treatments (MAT) for Opioid use Disorder (OUD) Among Pregnant Women with Commercial Insurance

    May 1, 2018, 00:00

  • Return on Investment (ROI) of Value-Based Insurance Design (VBID) Programs for Diabetic Patients

    May 1, 2018, 00:00

  • Comparison of Real-World Costs Between Patients with Rheumatoid Arthritis Treated with Subcutaneously-Administered Biologics Previously Treated with Another Biologic

    May 1, 2018, 00:00

  • Cost-Effectiveness of Therapeutic Drug Monitoring for Imatinib Administration in Patients with Chronic Myeloid Leukemia

    May 1, 2018, 00:00

  • Improving Medication Adherence By Better Targeting Interventions Using Artificial Intelligence - A Randomized Control Study

    May 1, 2018, 00:00

  • Patient Preferences for Health States Following Alternative Management Options for Ductal Carcinoma in Situ

    May 1, 2018, 00:00

  • Indirect Costs of a Relapse in Schizophrenia in Mexico

    May 1, 2018, 00:00

  • Outcomes Among Medicaid Recipients with Schizophrenia Treated with Once-Every-Three Month Paliperidone Palmitate

    May 1, 2018, 00:00

  • Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients with Migraine- Results from Two Global Phase 3 Clinical Trials

    May 1, 2018, 00:00

  • Outcomes Among Patients Prescribed Atypical Long-Acting Injectables Vs Oral Antipsychotic Therapy Following an Acute Event for Schizophrenia

    May 1, 2018, 00:00

  • One-Year Clinical Outcomes In Patients With Acute Coronary Syndrome In Tianjin, China

    May 1, 2018, 00:00

  • Health Care Costs Associated with Different Biologic Treatment Patterns Among U.S. Medicare Patients with Psoriasis

    May 1, 2018, 00:00

  • Gastrointestinal Events in Melanoma Patients Treated with Ipilimumab and Nivolumab

    May 1, 2018, 00:00

  • Comparison of All-Cause Mortality and All-Cause Hospitalization Risk for Medications to Treat Alzheimer’s Disease

    May 1, 2018, 00:00

  • Cost-Effectiveness of Crizotinib for Second and Third-Line Treatment of Non-Small Cell Lung Cancer in Ecuador

    May 1, 2018, 00:00

  • Cost-Effectiveness Of Rivaroxaban Compared With Enoxaparin Plus Warfarin For The Treatment Of Acute Deep Vein Thrombosis In China

    May 1, 2018, 00:00

  • Cost-Utility Analysis of Initial Treatment with Apremilast Versus Methotrexate in Systemic-Naïve Patients with Plaque Psoriasis

    May 1, 2018, 00:00

  • A Comparison of T2DM Patient Characteristics in 2009-2012 Vs. 2013-2016 Using Data from the Malaysian National Diabetes Registry

    May 1, 2018, 00:00

  • Diffusion without Eviden A Study on High-Risk Medical Devices

    May 1, 2018, 00:00

  • Projected Medicare Savings Associated with Lowering the Risk of Total HIP Arthroplasty Revision- An Administrative Claims Database Analysis

    May 1, 2018, 00:00

  • An Appraisal of the Quality of Economic Evidence in Cost-Effectiveness and Cost-Utility Studies Identified Via Systematic Review for B-Type Natriuretic Peptide-Guided Therapy in Heart Failure Management Patients

    May 1, 2018, 00:00

  • Experiences of Health and Social Inequalities in African Asylum Seekers and Refugees In Manchester, UK- A Thematic Analysis

    May 1, 2018, 00:00

  • Comparison of Video-Assisted Thoracic Surgery Segmentectomy (VATS-S) Versus Video-Assisted Thoracic Surgery Lobectomy (VATS-L) for Stage I Non-Small Cell Lung Cancer (NSCLC-I) in Chinese Patients- A Systemic Review and Meta-Analysis

    May 1, 2018, 00:00

  • Orphan legislation - Leave No One Behind?

    May 1, 2018, 00:00

  • Economic Evaluation of the Confirmatory Antibody Assay Against HIV-1 and HIV-2 (Geenius™ HIV 1/2 Supplemental Assay) as Confirmatory and Differentiation HIV Test

    May 1, 2018, 00:00

  • Leveraging Social Media to Explore Patient Experiences in Neovascular Age-Related Macular Degeneration

    May 1, 2018, 00:00

  • United States Valuation of EQ-5D-5L Health States- An Initial Model Using a Standardized Protocol

    May 1, 2018, 00:00

  • Prevalence and Correlates of Pharmacy Closure in the United States, 2009-2015

    May 1, 2018, 00:00

  • Quantifying the Monitoring Burden of Multiple Sclerosis (MS) Treatment in the United Kingdom (UK)- Feasibility Phase for an Observational Time and Motion (TM) Study

    May 1, 2018, 00:00

  • Social and Economic Impact of Patients with Metastatic Breast Cancer in Brazil

    May 1, 2018, 00:00

  • Association of the Hospital Cost for Copd with GDP Per Capita- Evidence for Brazilian States, 2000-2014

    May 1, 2018, 00:00

  • Cost-Minimization Analysis of Biological Drugs in the Treatment of Psoriatic Arthritis from a Brazilian Perspective

    May 1, 2018, 00:00

  • 12-Month Healthcare Utilization In Medicare Fee-For-Service Patients With Clinically Significant Mitral Regurgitation

    May 1, 2018, 00:00

  • Employer-Perspective Cost Comparison of Surgical Treatments for Abnormal Uterine Bleeding

    May 1, 2018, 00:00

  • Cost-Utility Analysis of Trabecular Micro-Bypass Stents Versus Laser Trabeculoplasty for Patients with Open-Angle Glaucoma in Colombia

    May 1, 2018, 00:00

  • Costs of Complications in Laparoscopic Bariatric Surgery

    May 1, 2018, 00:00

  • 1. Indirect Treatment Comparison of Pembrolizumab Versus Standard-of-Care for Relapsed and Refractory Classical Hodgkin’s Lymphoma Using Time-Varying Hazard Ratios

    May 1, 2018, 00:00

  • Identification of Potentially Inappropriate Cardiovascular Prescriptions in the Elderly Using Beers Criteria in Colombia

    May 1, 2018, 00:00

  • The Long-Term Social Value Of Better Targeting G-Csf Therapy To Cancer Patients At Risk Of Febrile Neutropenia

    May 1, 2018, 00:00

  • The Budget Impact of Deflazacort for the Treatment of Duchenne Muscular Dystrophy (DMD)

    May 1, 2018, 00:00

  • “It’s Tough to Make Predictions, Especially About the Future”- Comparing Life Expectancy Predictions Based on Period Versus Cohort Life Tables

    May 1, 2018, 00:00

  • The Impact of Judicialization of Eculizumab on the Budget of Brazilian Health System

    May 1, 2018, 00:00

  • Abuse-Deterrent Formulations of Opioids- Effectiveness and Economic Impact

    May 1, 2018, 00:00

  • Understanding Sepsis Recognition and Management in Emergency Room Settings to Improve Patient Outcomes

    May 1, 2018, 00:00

  • Effect of Painful Lumbosacral Radiculopathy on Employment and Quality of Life Among Patients in Europe

    May 1, 2018, 00:00

  • Patient Satisfaction, Adherence , Compliance , Persistence in Healthcare . Preliminary Real-World Evidence (RWE) in a Private Health Insurance in Latin America Country

    May 1, 2018, 00:00

  • The Impact Of Cluster Selection Methods In Two-Stage Bootstrapping To Assess Uncertainty In Health Economic Outcomes In Cluster Randomized Controlled Trials

    May 1, 2018, 00:00

  • The Burden of Hypoglycemia in Patients With Insulin-Treated Diabetes Mellitus in China- Analysis of Medical Record Data

    May 1, 2018, 00:00

  • Cost-Effectiveness of Staged Direct-Acting Antiviral Treatment Policies in an Integrated Healthcare System

    May 1, 2018, 00:00

  • Patterns Of Use And Quality Of Life (QOL) Associated With The Utilization Of Antidepressants Amongst Cancer Patients With Depression

    May 1, 2018, 00:00

  • Cost-Effectiveness and Budget Impact of Introducing Long Acting Atypical Antipsychotics in the United States Healthcare System

    May 1, 2018, 00:00

  • Examination of Osteoporosis and Subsequent Fracture Risk

    May 1, 2018, 00:00

  • Assessing the Benefits of Co-Pay Card Usage Among Diabetic Patients in Canada

    May 1, 2018, 00:00

  • The Use of Real World Data to Define The Prevalence, Severity, and Etiology of Mitral Valve Regurgitation

    May 1, 2018, 00:00

  • Clinical Characteristics, Rescue Treatments, Health Resources Utilization, and Medical Costs Associated with Chinese Chronic Hepatitis B Patients with Drug Resistance to Neucleot(S)IDE Analogues- A Retrospective Cohort Study

    May 1, 2018, 00:00

  • Health Care Cost in the Last Year of Life In People with a Private Health Policy from Colombia

    May 1, 2018, 00:00

  • Lack of Association Between Beta Blocker Use and Reduction in Joint Pain and Analgesic Use Among Participants with Symptomatic Radiographic Knee Osteoarthritis

    May 1, 2018, 00:00

  • Practical Implications of Flexible Work Arrangements – A Survey of Selected Pharmaceutical/Healthcare Organizations

    May 1, 2018, 00:00

  • Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer- Real-World Clinical Characteristics, Treatment Patterns, And Health Care Resource Utilization In Europe

    May 1, 2018, 00:00

  • Cost of Laparoscopic Fundoplication for Gastroesophageal Reflux Disease (GERD) in the US Adult Population

    May 1, 2018, 00:00

  • Impact of Elagolix on Health-Related Quality of Life Among Patients with Moderate to Severe Endometriosis-Associated Pain- Analysis of EQ-5D-5L Data from a Phase III Randomized Controlled Trial

    May 1, 2018, 00:00

  • Application of Generalized Structural Equation Model in a 41-Year Cohort Study of Incident and Survival Outcomes of Rheumatoid Arthritis (RA) Cases and Matched Non-Ra Controls

    May 1, 2018, 00:00

  • Incremental Healthcare Resource use and Costs Associated with Skeletal-Related Events in Patients with Bone Metastases from Solid Tumors

    May 1, 2018, 00:00

  • Attitude of Healthcare Professionals Towards Understanding the Issue of Antimicrobial Resistance

    May 1, 2018, 00:00

  • Healthcare Resource Utilisation and Costs of Agitation in People with Demetia Living in Care Homes - The Managing Agitation and Raising Quality of Life in Dementia (MARQUE) Study

    May 1, 2018, 00:00

  • Efficacy and Safety of Everolimus in the Treatment of Metastatic Breast Cancer- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00

  • Towards IRP Common Ground- To What Extent are European Countries Aligned in How they use International Reference Pricing?

    May 1, 2018, 00:00

  • Estimating Patient Utility in Migraine- Longitudinal Analysis of Erenumab Clinical Trial Data

    May 1, 2018, 00:00

  • Anti-PD1 Drugs- Are The Reimbursed Indications Of The Marketing Authorization Respected?

    May 1, 2018, 00:00

  • Association Rule Mining to Identify Frequent Concomitant Use of Prescribed Medications in the Population

    May 1, 2018, 00:00

  • The Hospital Burden Of Amputation In Patients With Peripheral Artery Disease

    May 1, 2018, 00:00

  • Prevalence of Pneumococcal Vaccination in a Recently Resettled Refugee Population

    May 1, 2018, 00:00

  • Nice-ly Paving the Way? Dynamic Pricing- The Future of Pricing and Reimbursement?

    May 1, 2018, 00:00

  • The Cost-Effectiveness Analysis Of Shenfu Injection Combined With Conventional Therapy For Heart Failure Patients In China

    May 1, 2018, 00:00

  • Cost-Effectiveness of Three Different Strategies for the Treatment of First Recurrent Clostridium Difficile Infection Diagnosed in a Community Setting

    May 1, 2018, 00:00

  • The use of Historical Trial Data to Inform Extrapolations of Immature Survival Data within a Bayesian Framework in Comparison to Standard Approaches

    May 1, 2018, 00:00

  • Patterns Of Health Service Utilization Among Patients Undergoing Hematopoietic Cell Transplantation — A Person-Centered Approach

    May 1, 2018, 00:00

  • Economic Evaluation of the Use of Linear Accelerator of Electrons for Intraoperative Radiotherapy in the Treatment of Rectal Cancer in Mexico

    May 1, 2018, 00:00

  • The Economic Burden Among Patients with Treatment Resistant Depression in US Claims Data

    May 1, 2018, 00:00

  • Burden of Illness in Ostomates- A German-Based Claims Database Analysis

    May 1, 2018, 00:00

  • Budget Impact of Etanercept Versus Adalimumab for Treatment of Rheumatoid Arthritis In Biologic-Naïve Patients in the United Kingdom

    May 1, 2018, 00:00

  • Treatment with Prostacyclins Delays and Reduces Hospital Readmissions Among Pah Patients

    May 1, 2018, 00:00

  • A Discrete Event Simulation Model For A Pharmacogenomics Test For Statin-Induced Myopathy In Patients Initiating A Statin In Secondary Cardiovascular Prevention

    May 1, 2018, 00:00

  • Short-Term Cost-Effectiveness of Glucagon-Like Peptide-1 Receptor Analogues Versus Sodium-Glucose Cotransporter-2 Inhibitors as Second-Line Add-On Therapy for Type 2 Diabetes in the United States

    May 1, 2018, 00:00

  • Use And Expense Of Antihypertensive Medicines In U.S. Hypertensive Adults

    May 1, 2018, 00:00

  • Real Life Use of Dressings in the Treatment of Leg Ulcers and Diabetic Foot Ulcers

    May 1, 2018, 00:00

  • Baseline Knowledge About Vaccines and Vaccine-Preventable Diseases Among Older Adults- Preliminary Baseline Analysis of the Vaccine Education Through Pharmacists and Senior Centers (VEPSC) Study

    May 1, 2018, 00:00

  • Evaluation of Antihyperglycemic Medication Cessation As An Acceptable Proxy for Glycemic Control after Bariatric Surgery

    May 1, 2018, 00:00

  • Systematic Review and Decision Analysis for Current and Experimental Therapies for Wiskott-Aldrich Syndrome

    May 1, 2018, 00:00

  • Hepatocellular Carcinoma In The Brazilian Public Health System- A Burden Of Illness Model

    May 1, 2018, 00:00

  • Cost Effectiveness Analysis Of Evolocumab, A PCSK9 Inhibitor, From The US Societal Perspective

    May 1, 2018, 00:00

  • Comparing Outcomes Between Fixed and Flexible Treatment Intervals with Botulinum Neurotoxins Type A in the Management Of Blepharospasm and Cervical Dystonia – A Cost-Effectiveness Analysis from the Romanian Perspective

    May 1, 2018, 00:00

  • Costs Associated with Follicular Lymphoma Among Medicare Beneficiaries- An Incremental Cost Analysis

    May 1, 2018, 00:00

  • Effect of Patient Involvement and Message Format on Perceived Susceptibility and Severity to Breast Cancer

    May 1, 2018, 00:00

  • Projecting Overall Survival (OS) With Immuno-Oncology (IO) Treatments- Application of Alternative Approaches in Metastatic Merkel Cell Carcinoma (MMCC)

    May 1, 2018, 00:00

  • Defining and Estimating the Cure Fraction Bias in Survival Modelling of Novel Immuno-Oncology Therapy Agents in Small-Cell Lung Cancer

    May 1, 2018, 00:00

  • Impact of Elagolix on Quality of Life Measured By SF-12 in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids- Evidence from A Phase 2B Randomized Trial

    May 1, 2018, 00:00

  • Why Most Budget Impact Analyses of Medicines are not Accurate? Quality of Budget Impact Analysis Needs to be Improved

    May 1, 2018, 00:00

  • Accessing Newly Implemented Claims Databases In Southeast-Asia- Advancing Health Research

    May 1, 2018, 00:00

  • Evaluation of Adherence and its Predictors Among Persons of Ethiopian Descent in Washington DC

    May 1, 2018, 00:00

  • Can We Make Better Decisions If We Remove Quality of Life from the Value Equation?

    May 1, 2018, 00:00

  • Geographic Variation in Opioid Related Outpatient Healthcare Utilization in the United States- A Retrospective Study of a Large Health System’s Claims Data

    May 1, 2018, 00:00

  • A Wrinkle In Time- When Survival Estimates Change Over The Observation Period

    May 1, 2018, 00:00

  • Budget Impact Analysis of Biologic Dmards in Colombia

    May 1, 2018, 00:00

  • Investigating Adherence in Adults with Type 2 Diabetes (T2DM) Prescribed Antiplatelet Medications for Secondary Prevention Following Acute Coronary Syndrome (ACS) Using Large UK Healthcare Databases

    May 1, 2018, 00:00

  • ICD-Coded Information on Sites of Metastasis in Oncology Real-World Data is Specific but Not Sensitive

    May 1, 2018, 00:00

  • Improving the Quality and Efficiency of Care Delivery Through In-Depth Understanding of the China Healthcare Digital Landscape

    May 1, 2018, 00:00

  • Utilizing the 3S Framework to Understand the Patient’s Preference when Addressing Non-Adherence in Patients with Diabetes

    May 1, 2018, 00:00

  • Insulin Delivery Systems for Type 1 Diabetes Mellitus - A Comparison Using a Decision Analysis Modeling Approach

    May 1, 2018, 00:00

  • Are whole Exome and whole Genome Sequencing Approaches Cost-Effective? A Systematic Review of the Literature

    May 1, 2018, 00:00

  • Economic Guidance Panel Changes to Minimize Post-Progression Treatment Effects by the Pan-Canadian Oncology Drug Review in Economic Evaluations Assessing Cancer Drugs

    May 1, 2018, 00:00

  • Linguistic Validation of the Endometriosis Treatment Satisfaction Questionnaire (ETSQ) in 3 Languages for Endometriosis Patients

    May 1, 2018, 00:00

  • Clozapine and Agranulocytosis- Impact of the Risk Evaluation and Mitigation Strategy Program

    May 1, 2018, 00:00

  • Income/Assets and Race/Ethnicity Effects on Drug Adherence Within the Medicare Part D Low Income Subsidy Population

    May 1, 2018, 00:00

  • Outcomes Related to Opioid Prescribing after Academic Detailing- A Review of Literature

    May 1, 2018, 00:00

  • Treatment Pattern And Direct Medical Costs Among Patients With Lung Cancer In China

    May 1, 2018, 00:00

  • Use of Antibiotics for Children with Acute Respiratory Tract Infections and Its Effects on Outpatient Revisits

    May 1, 2018, 00:00

  • Rapid Estimation of Smoking-Attributable Mortality and Economic Costs

    May 1, 2018, 00:00

  • Is Facebook Addiction Leading Adolescents to Depression? Evidence from Dhaka City, Bangladesh

    May 1, 2018, 00:00

  • Interpretation of Change In Patient-Reported Outcomes in Treatment-Resistant Depression

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Sofosbuvir/Velpatasvir in Genotype 1 Hepatitis C Infected Patients in Mexico

    May 1, 2018, 00:00

  • Hospital Lenght of Stay and Costs In Patients with Acute Myeloid Leukemia- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • The Study of the Present Situation and Problems Related to the Drug Safety Monitoring Acted by Pharmacists of Hospitals Under the New Medical Reform in China—Based on the Result of in-Depth Interview

    May 1, 2018, 00:00

  • Economic Analysis of D-Dimer Test used for the Diagnosis of Venous Thromboembolism in Colombia

    May 1, 2018, 00:00

  • Rehospitalization in Patients with Chronic Obstructive Pulmonary Disease- Important Risk Factors and Risk Prediction Model Using Clarification Random Forest

    May 1, 2018, 00:00

  • Adherence or Persisten Is that the Question?

    May 1, 2018, 00:00

  • Examining the Target Population of Orphan Drugs- Are Drugs Exceeding the Intended Purposes of The Orphan Drug Act?

    May 1, 2018, 00:00

  • Trends in Hospitalization Charges for Patients Diagnosed with Elixhauser Comorbidites as a Function of Body Mass Index

    May 1, 2018, 00:00

  • Trends in Type 2 Diabetes Inpatient and Emergency Department Visits and Outcomes Using Electronic Health Record Data

    May 1, 2018, 00:00

  • First Steps in Choosing Appropriate Instruments/Measurements for a Core Outcome Set- An Example from Corehem

    May 1, 2018, 00:00

  • Developing an Algorithm to Identify Patients with Acute Intermittent Porphyria in an Administrative Claims Database

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Anidulafungin Versus Fluconazole for Invasive Candidiasis in Malaysia

    May 1, 2018, 00:00

  • Cost Effective Only At A Zero Pri A Real-Time Scenario In Untreated Braf V600 Mutated Metastatic Melanoma?

    May 1, 2018, 00:00

  • Uptake of all-oral Direct Acting Antivirals in Hepatitis C Virus-Infected Patients with Substance use Disorder

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay And Costs in Patients with Chronic Lymphoid Leukemia- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Using Geographic Information System (GIS) to Study the Utilization Trends of Incretin-Based and Peptides Therapies for Type 2 Diabetes in the US Medicaid Programa

    May 1, 2018, 00:00

  • Acute Infection Following Transfusion Among Inpatient Elderly in the U.S., as Recorded by Large Administrative Databases During 2012-2017

    May 1, 2018, 00:00

  • Quality of Life in Patients with Osteoporosis- A Us Cross-Sectional Survey

    May 1, 2018, 00:00

  • Health Care Costs And Resource Utilization Prior To Initiation Of A Prostacyclin Receptor Agonist For Pulmonary Arterial Hypertension In A Real-World Database Representing A Large US Health Plan

    May 1, 2018, 00:00

  • Treatment Patterns and Costs Associated with Diffuse Large B-Cell Lymphoma—A Retrospective Analysis of Claims

    May 1, 2018, 00:00

  • Prevalence and Factors Associated with Hospital Admission Among US Adults- Nhanes 2005-2014

    May 1, 2018, 00:00

  • Low-Density Lipoprotein Cholesterolgoal Attainment Based on 2015 Korean Dyslipidemia Guidelines

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Absorbable Adhesion Barrier in Preventing Adhesion Formation after Open Gynecologic Surgeries in China

    May 1, 2018, 00:00

  • Physicians’ Perceived Awareness of Patients’ Medications- A Cross-Sectional Survey

    May 1, 2018, 00:00

  • Patient-Reported Outcome Measures in the FDA Pilot Compendium- Meeting Today’s Standards for Patient Engagement in Development?

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Transcatheter Aortic Valve Replacement in Inoperable Patients with Severe Aortic Stenosis in Mexico

    May 1, 2018, 00:00

  • Economic Burden of Advanced Cervical Cancer- A Systematic Literature Review

    May 1, 2018, 00:00

  • Assessment of Health Outcomes Based on Patient Activation Level

    May 1, 2018, 00:00

  • The Development of the Guide to Economic Analysis and Research (GEAR) Online Resource for Low- and Middle-Income Countries’ Health Economics Practitioners- A Commentary

    May 1, 2018, 00:00

  • Table of Contents

    May 1, 2018, 00:00

  • Hospital Budget Impact Analysis For Giapreza In The Treatment Of Severe Distributive Shock In The Intensive Care Unit

    May 1, 2018, 00:00

  • Economic Impact of Diabetes Self-Management Education

    May 1, 2018, 00:00

  • Length of Stay, Hospitlization Cost, and In-Hospital Mortality Associated with Tumor Lysis Syndrome Among Patients with Chronic Lymphocytic Leukemia

    May 1, 2018, 00:00

  • Survival of Patients with Diabetes Mellitus By Residential Area in Colombia, 2008-2017

    May 1, 2018, 00:00

  • Examinations Of Attitudes Of Romany Minority Women Towards Cervical Cancer Screening

    May 1, 2018, 00:00

  • Revealed Preference for Additional Healthcare Spend and the Institute for Clinical and Economic Review's (ICER) Budget Impact Threshold

    May 1, 2018, 00:00

  • Consistency of Drug Labels for Therapeutically Equivalent Medications

    May 1, 2018, 00:00

  • The Budget Impact of Brodalumab for the Treatment of Moderate-to-Severe Plaque Psoriasis on U.S. Commercial Health Plans

    May 1, 2018, 00:00

  • Thai Adults’ Preferences and Willingness-To-Pay for Colorectal Cancer Screening- A Discrete Choice Experiment

    May 1, 2018, 00:00

  • Cost Estimation of Pharmacy Services and the Recommendation of New Charge Items in Hospitals of Southwest China

    May 1, 2018, 00:00

  • Extent and Predictors of Potentially Inappropriate Antidepressant Use Among Older Adults with Dementia and Major Depressive Disorder

    May 1, 2018, 00:00

  • The Impact Of Regulatory Accelerated Approval Schemes And Htas On Access To New Oncology Medicines- Evidence From 11 Countries

    May 1, 2018, 00:00

  • The Next Level in the Game of Playing for Formulary Preference

    May 1, 2018, 00:00

  • Economic Evaluation of the Nerve Conduction Measuring Device for the Diagnosis of Peripheal Diabetic Neuropathy

    May 1, 2018, 00:00

  • College Students' Preferences for Components of a Campus-Sponsored Program to Reduce Nonmedical Use of Prescription Stimulants

    May 1, 2018, 00:00

  • Biosimilars- The Challenge to Overcome Financial Incentives in a US Payer Market

    May 1, 2018, 00:00

  • Longitudinal Data from Activity Trackers Show that Those with Greater Inconsistency in Activity Levels are More Likely to Develop More Severe Depression

    May 1, 2018, 00:00

  • Femoral Shaft Fractures- Treatment Costs and Complication Risks – A Claims Database Analysis

    May 1, 2018, 00:00

  • Annual Direct Medical Cost of Pediatric Pulmonary Hypertension Health Care in Centro Medico Nacional 20 De Noviembre (Nmcissste, Mexico)

    May 1, 2018, 00:00

  • Designing Evidence Generation Plans for Digital Health Technologies to Gain Reimbursement Coverage in the us

    May 1, 2018, 00:00

  • Risk Based Characterization Applied to a Voluntary Insurer in Colombia

    May 1, 2018, 00:00

  • Temporal Trends in Treatment of Type 2 Diabetes Mellitus, 2007-2014

    May 1, 2018, 00:00

  • Economic Evaluation of the Advance Lubricath® Foley Catheter Tray® for Urinary Catheterization of Long Duration

    May 1, 2018, 00:00

  • Patient Preferences for Social Incentives for Medication Adheren A Discrete Choice Experiment

    May 1, 2018, 00:00

  • A Comparison of Long-Term Patient Outcomes after Heart Valve Replacement with Biological or Mechanical Valves in Medicare Beneficiaries

    May 1, 2018, 00:00

  • Trends and Risk Factors Associated with Severe Maternal Morbidity in Texas Women

    May 1, 2018, 00:00

  • The Impact of the Centers for Medicare and Medicaid Services (CMS) 2016 Update to the Two-Midnight Rule On Inpatient/Outpatient Status and Length of Stay for Cardiac Ablation Procedures

    May 1, 2018, 00:00

  • Disease Burden Among Patients with Multiple Sclerosis Not Receiving Disease Modifying Treatments in Europe and the United States

    May 1, 2018, 00:00

  • Atypical Antipsychotic Use Among Long-Term Care Residents with Parkinson's Disease and Comorbid Depression

    May 1, 2018, 00:00

  • Utilization And Impact Of Value Assessment Frameworks On Payer Decisions Regarding Chimeric Antigen Receptor T-Cell Therapies

    May 1, 2018, 00:00

  • Are Single-Patient use Electrocardiograph Cable and Lead Systems During Coronary Artery Bypass Graft Monitoring a Benefit to Healthcare Payers- A Budget Impact Analysis

    May 1, 2018, 00:00

  • Cost-Utility Analysis Of Valsartan Versus Valsartan Plus Hydrochlorothiazide In Patients With Hypertension In The US

    May 1, 2018, 00:00

  • A Review of Nice Technology Appraisals in Oncology Using Single Arm Trials (SAT) Evidence

    May 1, 2018, 00:00

  • Global Growth in Public Healthcare- Emerging Markets Take the Wheel

    May 1, 2018, 00:00

  • Identifying Caregiver Priorities for Treatment Endpoints for Prader-Willi Syndrome with Best-Worst Scaling

    May 1, 2018, 00:00

  • Patient and Clinician Satisfaction with Pharmacological Stress Agents (PSAS) Used in Single Photon Emission Computerized Tomography Myocardial Perfusion Imaging (SPECT-MPI)

    May 1, 2018, 00:00

  • Potential Impact of Changes to Basket of Comparator Countries from PMPRB7 to Pmprb12 has on Canadian Product List Prices

    May 1, 2018, 00:00

  • Productivity Losses Among Patients with Migraine- An Analysis of Erenumab Clinical Trial Data

    May 1, 2018, 00:00

  • Claims-Based Data Sources Likely Underestimate Use of Human Insulin

    May 1, 2018, 00:00

  • Cost-Effectiveness of Treating Overactive Bladder With Mirabegron Versus Antimuscarinics in Mexico

    May 1, 2018, 00:00

  • Are FDA Accelerated Approvals Unconditional Approvals?

    May 1, 2018, 00:00

  • The Influencing of Hospitalization Costs Through Length of Stay Among Inpatients with Positive Antimicrobial Susceptibility Based on the Method of Structural Equation Model

    May 1, 2018, 00:00

  • Total Healthcare Expenditures Associated with Biological Anti-Rheumatic Drugs Use Among Medicare Beneficiaries with Rheumatoid Arthritis

    May 1, 2018, 00:00

  • A Cost-Utility Analysis of Atovaquone-Proguanil vs. Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria in the United States

    May 1, 2018, 00:00

  • Psychometric Evaluation of Questionnaires Assessing Injection Regimen Burden in Growth Hormone Deficient (GHD) Adults and Children Treated with Growth Hormone

    May 1, 2018, 00:00

  • Mapping the Gaps- Gender Differences in Preventive Cardiovascular Care Among Managed Care Members In Four Metropolitan Areas

    May 1, 2018, 00:00

  • Patient Characteristics and Treatment Patterns in Cancer Patients with Venous Thromboembolism in Korea

    May 1, 2018, 00:00

  • The Effect of Physical Activity During Pregnancy on Quality of Life

    May 1, 2018, 00:00

  • Healthcare Resource Use (HRU) Associated with Severe Adverse Events (AES) Of Interest in Adults With Relapsed or Refractory (R/R) B-Precursor Acute Lymphoblastic Leukemia (All) In Eu-4 Countries

    May 1, 2018, 00:00

  • United States Health Plan Cancer Concerns In 2018

    May 1, 2018, 00:00

  • What Is The Future Of Using Outcomes-Based Contracts Between Payers And Pharmaceutical Manufacturers To Gain Market Access For Advanced Oncologic And Biologic Agents?

    May 1, 2018, 00:00

  • Association of Appropriate Pharmacotherapy Management of Copd Exacerbation and Risk of Subsequent Readmission

    May 1, 2018, 00:00

  • The Comparative Efficacy, Safety, And Reactogenicity, of Herpes Zoster Vaccines- A Network Meta-Analysis

    May 1, 2018, 00:00

  • Value-Based Care In Oncology- Challenges And Barriers Amongst Community Oncologists

    May 1, 2018, 00:00

  • The Reporting Quality of Pharmacoeconomic Studies Before and After Publication of the Cheers Checklist

    May 1, 2018, 00:00

  • Accessing Medications in the United States- A Systemic Review of the Challenges and Barriers

    May 1, 2018, 00:00

  • Health Insurance Cost Related to the Additional Treatment and Complications of Patients Involved into Clinical Trials

    May 1, 2018, 00:00

  • Biosimilar Market Access – Comparing the US and European Markets

    May 1, 2018, 00:00

  • Trastuzumab Uptake In HER2-Positive Breast Cancer Patients- A Systematic Review And Meta-Analysis Of Observational Studies

    May 1, 2018, 00:00

  • Evaluation Of The Disease-Specific Items On The Eortc In Hepatocellular Carcinoma Patients Treated With Lenvatinib Or Sorafenib

    May 1, 2018, 00:00

  • Emphasizing Quality of Life in Treatment Recommendations for Node-Positive Stage III Non-Small Cell Lung Cancer

    May 1, 2018, 00:00

  • Cost Effectiveness Analysis of Intra-Articular Triamcinolone Acetonide Extended-Release Injectable Suspension (TA-ER) Versus Triamcinolone Acetonide Crystalline Suspension For Symptomatic Knee Osteoarthritis

    May 1, 2018, 00:00

  • Age and Racial Disparities in Human Pappilomavirus (HPV) Vaccination Series Completion in Mississippi Medicaid

    May 1, 2018, 00:00

  • Impact of Affordable Care Act on Medicare Disproportionate Share Hospital (DSH) Payments

    May 1, 2018, 00:00

  • Healthcare Cost Associated with Cardiac Implantable Electronic Device Infections- Using a National Health Insurance Claims Database

    May 1, 2018, 00:00

  • Hepatitis C Patient Characteristics Across Antiviral Treatment Eras in a Large Managed Care Organization

    May 1, 2018, 00:00

  • A Foot In The Door Or One Foot In The Grave? The Role Of Real World Evidence In Cancer Drugs Fund Re-Appraisals

    May 1, 2018, 00:00

  • The Cost of New Oral Anti-Diabetic Drugs in Canada and Internationally

    May 1, 2018, 00:00

  • Impact of European Medicines Agency (EMA) Clinical Trial Transparency Policies on Health Technology Assessment (HTA) Decisions In the UK

    May 1, 2018, 00:00

  • Age-Related Hospital Utilization Among Patients with Marfan Syndrome

    May 1, 2018, 00:00

  • Variation in Physician’s Recommendation of Blood Pressure Self-Monitoring in the United States- Results from Nhanes 2009 – 2014

    May 1, 2018, 00:00

  • A Real-World Data Analysis Evaluating the Time to Glycemic Control After Initiation of Basal Insulin in Type 2 Diabetic Patients

    May 1, 2018, 00:00

  • Out-of-Pocket Cost Burden and Price Elasticity of Demand for Ivacaftor use in Cystic Fibrosis

    May 1, 2018, 00:00

  • Cost-Effectiveness of Cetuximab for Left-Side Metastatic Colorectal Cancer in Ecuador

    May 1, 2018, 00:00

  • Financial Burden Over Time in Older Adults with Cancer, Heart Disease, or Diabetes

    May 1, 2018, 00:00

  • Potential Risks and Benefits for Using Nsaids in The Treatment of Rheumatoid Arthritis

    May 1, 2018, 00:00

  • Cost Effectiveness Analysis of Risperidone and Olanzapine in Schizophrenic Patients

    May 1, 2018, 00:00

  • Association Between Exenatide/Β2AR Use and Parkinson’s Disease Risk in Medicare Population

    May 1, 2018, 00:00

  • Treatment Patterns PSA

    May 1, 2018, 00:00

  • Comparison Of Bleeding Events, Strokes, And Myocardial Infarcts On Warfarin Or Dabigatran For Treatment Of Atrial Fibrillation- Results Of A Real-World Data Analysis

    May 1, 2018, 00:00

  • Shift in the Status Quo- How Biosimilar Interchangeability Can Lead to Significant Cost Savings

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay and Costs in Patients with Peripheral T-Cell Lymphoma (PTCL)- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Predictors of All-Cause Healthcare Payments Among Patients With Treatment-Resistant Major Depressive Disorder

    May 1, 2018, 00:00

  • Clinical and Economic Impact of Switching from Negative- or Neutral Displacement Needleless Connectors to Positive Displacement Needleless Connectors in Central Vascular Access Settings

    May 1, 2018, 00:00

  • Trends of Antibiotic Consumption in Intensive Care Units of Colombia, 2010-2016

    May 1, 2018, 00:00

  • Health Technology and Regulatory Assessment of Adherence and Improved Outcomes for Second Generation Antipsychotics in Schizophrenia

    May 1, 2018, 00:00

  • Cost-Effectiveness Evaluation of Ertapenem in the Treatment of Adult Patients with Community-Acquired Complicated Urinary Tract Infections

    May 1, 2018, 00:00

  • The Influence on Coping Style in Patients with Schizophrenia By Naikan Therapy

    May 1, 2018, 00:00

  • Epidemiology Of Hyperhidrosis in the United States- A Systematic Literature Review

    May 1, 2018, 00:00

  • Budget Impact Analysis (BIA) of Point-of-Care of HBA1C Monitoring in Belgian, German and Swiss Patients with Diabetes Mellitus Type II

    May 1, 2018, 00:00

  • Evaluation of Subcutaneous Rituximab Administration Impacts on Canadian Systemic Therapy Suites

    May 1, 2018, 00:00

  • Treatment Utilization Patterns Among Elderly Patients Diagnosed With Follicular Lymphoma In The United States Between 2000 And 2013

    May 1, 2018, 00:00

  • Budget Impact Analysis of Oritavancin for the Treatment of Moderate to Severe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) from a Hospital Perspective

    May 1, 2018, 00:00

  • Examining Job Satisfaction, Stress, Flexibility, And Career Success Factors in the Health Economics, Outcomes Research, And Market Access (HEORMA) Profession Based on a Global Cross-Sectional Study

    May 1, 2018, 00:00

  • New Structured Search Method that Allows Identify and Map Potential Patients with Cystic Fibrosis Not Yet Diagnosed

    May 1, 2018, 00:00

  • ICERS are Not All the Same. How Cost-Effectiveness Estimates Differ Between the UK and US

    May 1, 2018, 00:00

  • Association of Disease Modifying Antirheumatic Drugs (DMARD) and Tumor Necrosis Factor (TNF)- Alpha Inhibitor Therapy and Infection In Rheumatoid Arthritis Patients in a Medicaid Population

    May 1, 2018, 00:00

  • Effect of Vitamin D Supplementation on HIV Outcomes- A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    May 1, 2018, 00:00

  • Assessment of the Burden of Multiple Sclerosis On Family Caregivers By Patient Disability Severity

    May 1, 2018, 00:00

  • Clotting Factor (CF) Product Administration And Risk Of Thrombotic Adverse Events (TES) Among The Inpatient U.S. Elderly Medicare Beneficiaries, During 2009-2015 Study Period

    May 1, 2018, 00:00
  • «
  • 71 (current)
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »